GLIX-5

N/A

Report date: 2023/12/26 13:36:36
NMEFirst In Class

Base Information

Drug NameGLIX-5
Drug Alias NameGLIX-5GLIX5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMethylcytosine dioxygenase TET2 modulators
TargetsMethylcytosine dioxygenase TET2
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHemispherian AS
China Registration ClassN/A

Develop Information

Active CompaniesHemispherian AS
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A